Clinical Pharmacokinetics of Clopidogrel and Its Metabolites in Patients with Cardiovascular Diseases
Main Authors: | Karaźniewicz-Łada, Marta, Danielak, Dorota, Burchardt, Paweł, Kruszyna, Łukasz, Komosa, Anna, Lesiak, Maciej, Główka, Franciszek |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899497/ |
Similar Items
-
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis
by: Główka, Franciszek, et al.
Published: (2011) -
The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
by: Umemura, Kazuo, et al.
Published: (2016) -
Issues in the Pharmacokinetics of Trichloroethylene and Its Metabolites
by: Chiu, Weihsueh A., et al.
Published: (2006) -
Development and Validation of an HPLC Method for Simultaneous Quantification of Clopidogrel Bisulfate, Its Carboxylic Acid Metabolite, and Atorvastatin in Human Plasma: Application to a Pharmacokinetic Study
by: Croitoru, Octavian, et al.
Published: (2015) -
11β-Hydroxysteroid Dehydrogenase 2 in Preeclampsia
by: Kosicka, Katarzyna, et al.
Published: (2016)